Skip to Content

Simcor Approval History

  • FDA approved: Yes (First approved February 15th, 2008)
  • Brand name: Simcor
  • Generic name: niacin ER and simvastatin
  • Dosage form: Tablets
  • Company: Abbott
  • Treatment for: High Cholesterol

Simcor (niacin extended-release/simvastatin) is a fixed-dose combination lipid therapy used along with diet to lower levels of total cholesterol, LDL "bad" cholesterol and triglycerides, and to increase HDL "good" cholesterol.

Development History and FDA Approval Process for Simcor

Jul 29, 2010Approval Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
Feb 19, 2008Approval Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
Oct 22, 2007Abbott and Solvay Pharmaceuticals to co-promote Abbott's Simcor in the United States
Apr 20, 2007Abbott Submits New Drug Application for Simcor Combination Niaspan/Simvastatin Tablet

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.